CD23 shedding: Requirements for substrate recognition and inhibition by dipeptide hydroxamic acids

Inflammation Research

Volumn 51, Issue 2, 2002, Pages 85-90

  Mayer, Ruth J ^a   Flamberg, P L ^a   Katchur, S R ^a   Bolognese, B J ^a   Smith, D G ^a   Marolewski, A E ^a   Marshall, L A ^a   Faller, A ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

ADAM; CD23; IgE; Metalloprotease; Sheddase

Indexed keywords

CD23 ANTIGEN; DIPEPTIDE DERIVATIVE; HYDROXAMIC ACID DERIVATIVE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; IMMUNOGLOBULIN PRODUCTION; MACROPHAGE; MOLECULAR RECOGNITION; MONOCYTE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN SHEDDING; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0036185693     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02684008     Document Type: Review

References (47)

1. Treatment of allergic asthma with monoclonal anti-IgE antibody
2. Binding site for IgE of the human lymphocyte low-affinity Fce receptor (FceRII/CD23) is confined to the domain homologous with animal lectins
3. Expression, structure, and function of the CD23 antigen
4. Two species of human Fcε receptor II (FcεRII/CD23): Tissue specific and IL-4-specific regulation of gene expression
5. CD23 and B-cell Activation
6. The IL-4 receptor alpha-chain cytoplasmic domain is sufficient for activation of JAK-1 and STAT6 and the induction of IL-4 specific gene transcription
7. FcεRII/CD23: The low affinity receptor for IgE
8. Structure and function of the low affinity IgE receptor
9. Expression, regulation and function of human FcεRII(CD23) antigen
10. Regulation of cytokine production by soluble CD23: Costimulation of interferon γ secretion and triggering of tumor necrosis factor a release
11. Soluble CD23 directly activates monocytes to contribute to the antigen-independent stimulation of resting T cells
12. A new role for CD23 in inflammation
13. Mechanism of formation of human IgE-binding factors (soluble CD23): III. Evidence for a receptor (FcεRII)-associated proteolytic activity
14. CD23 (FcεRII) release from cell membranes is mediated by a membrane-bound metalloprotease
15. Mechanisms of formation of IgE-binding factors (soluble CD23) I. FceRII bearing B-cells generate IgE binding factors of different molecular weights
16. Der p I, a major allergen of the house dust mite proteolytically cleaves the low-affinity receptor for human IgE(CD23)
17. Spontaneous and ligand-induced endocytosis of CD23 (Fce receptor II) from the surface of B lymphocytes generates a 16-kDa intracellular fragment
18. Cleavage of the low-affinity receptor for human IgE (CD23) by a mite cysteine protease - Nature of the cleaved fragment in relation to the structure and function of CD23
19. Native and recombinant soluble CD23 fragments with IgE suppressive activity
20. CD23/FcεRII and its soluble fragments can form oligomers on the cell surface and in solution
21. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevent B lymphocyte proliferation and differentiation
22. Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen
23. Modulation of IL-4-induced human IgE production in vitro by IFN-gamma and IL-5: The role of soluble CD23 (s-CD23)
24. CD21 is a ligand for CD23 and regulates IgE production
25. CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18
26. Decrease in CD23+ B lymphocytes and clinical outcome in asthmatic patients receiving specific rush immunotherapy
27. Serum levels of soluble CD23 in patients with asthma or rhinitis monosensitive to Parietaria. Its relation to total serum IgE levels and eosinophil cationic protein during and out of the pollen season
28. Soluble CD23 is increased in allergy
29. Expression of adhesion molecules on mononuclear cells from individual with stable atopic asthma
30. Dominant effect of Ile50Val variant of the huamn IL-4 receptor alpha-chain in IgE synthesis
31. Membrane protein secretases
32. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor
33. A metalloprotease disintegrin that releases tumournecrosis-factor-α from cells
34. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors
35. Physiological enzymatic cleavage of leukocyte membrane molecules
36. Shedding of the lymphocyte L-selectin adhesion molecule is inhibited by a hydroxamic acid-based protease inhibitor
37. The importance of shedding of membrane proteins for cytokine biology
38. Mutational analysis of the membrane-proximal cleavage site of L-Selectin: Relaxed sequence specificity surrounding the cleavage site
39. Functional analysis of the domain structure of tumor necrosis factor-α converting enzyme
40. IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (FcεRII)
41. Hydroxamate-based inhibitors of low affinity IgE receptor (CD23) processing
42. Selective inhibition of low affinity IgE receptor (CD23) processing
43. Metalloprotease-disintegrin MDC9: Intracellular maturation and catalytic activity
44. Inhibition of CD23 processing correlates with inhibition of IL-4 stimulated IgE production in human PBL and hu-PBL-reconstituted SCID mice
45. Recombinant humanized mAb-E25, an antiIgE mAb, in birch pollen-induced seasonal allergic rhinitis